期刊文献+

Lenti-TK介导间充质干细胞对鼻咽癌CD133^+干细胞的靶向迁移及杀伤作用 被引量:2

Targeted migration and killing effect of mesenchymal stem cells infected with Lenti-TK on CD133^+ cancer stem cells in nasopharyngeal carcinoma
下载PDF
导出
摘要 目的:观察慢病毒-胸苷激酶(lentivirus-thymidine kinase,Lenti-TK)/间充质干细胞(mesenchymal stem cell,MSC)对鼻咽癌CD133+干细胞的靶向迁移及杀伤作用。方法:构建包含TK基因的重组慢病毒表达载体Lenti-TK,感染MSC后得到Lenti-TK-MSC,RT-PCR及Western blotting检测Lenti-TK-MSC中HA-TK的表达。免疫磁珠法从鼻咽癌5-8F细胞中分选CD133+细胞;Transwell小室迁移实验检测Lenti-TK-MSC对CD133+5-8F细胞的趋向性;Lenti-TK-MSC联合更昔洛韦(ganciclovir,Lenti-TK-MSC/GCV)与CD133+5-8F细胞共培养,CCK-8试剂盒检测其对细胞的杀伤作用和旁观者效应。结果:成功构建重组慢病毒载体Lenti-TK,其滴度为1×108UT/ml,Lenti-TK(MOI=50)感染MSC 72 h时,感染效率达(95.1±0.1)%。Lenti-TK-MSC迁移至CD133+5-8F细胞组的细胞数明显多于CD133-5-8F细胞组、未分选5-8F细胞组[(83.0±8.7)vs(29.6±5.3)、(38.3±5.2),P=0.000]。Lenti-TK-MSC/GCV处理组与单独GCV处理组、Lenti-TK-MSC/GCV条件培养液(即Lenti-TK-MSC加入1 mg/L GCV培养48 h的培养上清)处理组相比,CD133+5-8F细胞的存活率明显降低[(37.2±2.3)%vs(98.5±3.1)%、(83.8±3.4)%,P=0.000]。Lenti-TK-MSC数量达到混合细胞总数(Lenti-TK-MSC和CD133+5-8F细胞)的20%时,CD133+5-8F细胞存活率为(68.2±2.3)%,表现出明显的旁观者杀伤效应。结论:Lenti-TK感染后MSC对鼻咽癌CD133+5-8F细胞具有靶向迁移及杀伤作用。 Objective: To investigate the targeted migration and killing effect of mesenchymal stem cells (MSCs) infected with Lenti-TK (thymidine kinase) vector on CD133 + cancer stem cells in nasopharyngeal carcinoma. Methods: The recombinant lentiviral expression vector containing TK gene (Lenti-TK) was constructed and transduced into MSC (Lenti-TK-MSC). Fusion tag-TK (HA-TK) expression was verified by RT-PCR and Western blotting. CD133 +cells were sorted from nasopharyngeal carcinoma 5-8F cells by immunomagnetic beads. The chemotactic ability of Lenti-TK-MSC to CD133 +5-8F cells was analyzed by Transwell assay. The CD133 + 5-8F cells were co-cultured with Lenti-TK-MSC and GCV to detect its killing effect on cells by CCK-8 Kit. Results: The recombinant lentivirus vector Lenti-TK was success- fully constructed with titer being 1 ×l08 UT/ml. The transduction efficiency of Lenti-TK to MSC was ( 95.1 ± 0.1 ) %, 72 h after transduction at an MOI of 50. The migration number of Lenti-TK-MSC to CD133 +5-8F cells was more than that to CD133-5-8F cells and 5-8F cells ( [83.0 ±8.7] vs [29.6±5.3] vs [38.3 ±5.2] ;P =0.000). The Lenti-TK-MSC/ GCV treatment significantly inhibited the growth of the CD133 + 5-8F cells compared with the GCV group and the Lenti- TK-MSC/GCV condition medium group (the culture supernatant of Lenti-TK-MSC treated with 1 mg/L GCV for 48 h) ([37.2±2.31% vs [98.5±3.11% vs [83.8±3.41%, P=0.000), with the cell survival being (68.2±2.3)%when the proportion of Lenti-TK-MSC was 20%, which showed a significant bystander killing effect. Conclusion: Lenti- TK infected MSC exert targeted migration and killing effects on CD133 +5-8F cells from nasopharyngeal carcinoma.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2013年第2期145-152,共8页 Chinese Journal of Cancer Biotherapy
基金 广东省科技计划资助项目(No.2010B031200009)~~
关键词 鼻咽癌 CD133+细胞 间充质干细胞 肿瘤干细胞 肿瘤靶向基因治疗 旁观者效应 nasopharyngeal carcinoma CD133 + cell mesenchymal stem cell cancer stem cell tumor targeted genetherapy bystander effect
  • 相关文献

参考文献3

二级参考文献16

  • 1李春晖,焦保华,张庆九,耿少梅,白保忠,郭二坤,卢圣奎.树突状细胞制备脑胶质瘤疫苗的体外研究[J].中国神经精神疾病杂志,2005,31(2):149-151. 被引量:4
  • 2李春晖,焦保华,康春生,刘晓智.骨髓基质干细胞移植对大鼠胶质瘤局部微环境的影响[J].中国临床神经科学,2006,14(4):358-361. 被引量:3
  • 3Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med, 1997, 3(7): 730.
  • 4Al-Hajj M, Wicha MS, Benito-Hemandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA, 2003, 100(7): 3983.
  • 5Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res, 2003, 63(18) : 5821.
  • 6Kim CF, Jackson EL, Woolfenden AE, et al. Identification of bron chioalveolar stem cells in normal lung and lung cancer. Cell, 2005, 121(6) : 823.
  • 7Xin L, Lawsonn DA, Witte ON. The Scal cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate p rostate tumorigenesis. Proc Natl Acad Sci USA, 2005, 102(19): 6942.
  • 8Zhang HB, Ren CP, Yang XY, et al. Identification of label-retaining cells in nasopharyngeal epithelia and nasopharyngeal carcinoma tissues. Histochem Cell Biol, 2007, 127(3) : 347.
  • 9Wang J, Guo LP, Chen LZ, et al. Identification of cancer stem cell like side population cells in human nasopharyngeal carcinoma cell line Cancer Res, 2007, 67(8): 3716.
  • 10Richardson GD, Robson CN, tang SH, et al. CD133, a novel marker for human prostatic ep ithelial stem cells. J Cell Sci, 2003, 117: 3539.

共引文献44

同被引文献16

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部